2YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Prinomastat | 普马司他 | 192329-42-3 |
| Arhalofenate | 4-氯-ALPHA-[3-(三氟甲基)苯氧基]苯乙酸 2-(乙酰基氨基)乙酯 | 24136-23-0 |
| Ethynylcytidine | 1KG | 备注:厂家优势供应 | 180300-43-0 |
| AZD1283 | AZD-1283 | 919351-41-0 |
| Fiboflapon | FIBOFLAPON | 936350-00-4 |
| ETC-159 | 1,2,3,6-四氢-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-哒嗪基)-7H-嘌呤-7-乙酰胺 | 1638250-96-0 |
| DM1-SMe | N2'-去乙酰基-N2'-[3-(甲基二硫基)-1-氧代丙基]美登素 | 138148-68-2 |
| Acumapimod (BCT-197) | Acumapimod (BCT-197) | 836683-15-9 |
| BFH772 | CS-2412 | 890128-81-1 |
| Avacopan | CS-2731 | 1346623-17-3 |
| VX-787 | VX-787 | 1629869-44-8 |
| Pyridostatin TFA salt | CS-2156 | 1472611-44-1 |
| Leniolisib | LENIOLISIB | 1354690-24-6 |
| Indisulam | N-(3-氯-1H-吲哚-7-基)-1,4-苯二磺酰胺 | 165668-41-7 |
| EPZ020411 | EPZ020411 盐酸盐的形式 | 1700663-41-7 |
| Fevipiprant | 非韦匹仑 | 872365-14-5 |
| BAY 1217389 | CS-2361 | 1554458-53-5 |
| FIIN-3 | FIIN-3 | 1637735-84-2 |
| Batefenterol | BATEFENTEROL | 743461-65-6 |
| UK-371804 | 化合物UK371804 | 256477-09-5 |
| Fluralaner | - | 864731-61-3 |
| Belizatinib (TSR011) | CS-2493 | 1357920-84-3 |
| Zuclopenthixol | 珠氯噻醇 | 53772-83-1 |
| Mitoquinone mesylate, ethanol solution | 米托蒽醌甲磺酸盐 | 845959-50-4 |
| Pexacerfont | 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-A]-1,3,5-三嗪-4-胺 | 459856-18-9 |
| PTX-100 (GGTI-2418) | 化合物 T11396 | 501010-06-6 |
| Flumatinib | 氟马替尼 | 895519-90-1 |
| CPI-169 | 化合物CPI169 | 1450655-76-1 |
| UNC-2025 | 反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 | 1429881-91-3 |
| Acalabrutinib (ACP-196) | 阿卡替尼 | 1420477-60-6 |
| Ibiglustat | GENZ-682452 | 1401090-53-6 |
| Acelarin (NUC-1031) | N-(2'-脱氧-2',2'-二氟-P-苯基-5'-胞苷酰)-L-丙氨酸苄酯 | 840506-29-8 |
| GSK621 | 6-氯-5-(2'-羟基-3'-甲氧基-[1,1'-联苯]-4-基)-3-(3-甲氧基苯基)-1H-吡咯并[3,2-D]嘧啶-2,4(3H,5H)-二酮 | 1346607-05-3 |
| Gosogliptin | (3,3-二氟吡咯烷-1-基)[(2S,4S)-4-[4-(嘧啶-2-基)哌嗪-1-基]吡咯烷-2-基]甲酮 | 869490-23-3 |
| Briciclib | BRICICLIB | 865783-99-9 |
| Osilodrostat (LCI699) | LCI 699 | 928134-65-0 |
| JNJ-42165279 | N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺 | 1346528-50-4 |
| Peficitinib | 培菲替尼 | 944118-01-8 |
| AMG-319 | AMG319 | 1608125-21-8 |
| Nazartinib (EGF816) | EGF816 | 1508250-71-2 |
| DEL-22379 | N-[2,3-二氢-3-[(5-甲氧基-1H-吲哚-3-基)亚甲基]-2-氧代-1H-吲哚-5-基]-1-哌啶丙酰胺 | 181223-80-3 |
| Eleclazine | GS6615;GS 6615 | 1443211-72-0 |
| VU0409551 | 1363281-27-9 | 1363281-27-9 |
| Ombrabulin HCl | AVE8062A | 253426-24-3 |
| EMD534085 | N-[2-(二甲基氨基)乙基]-N'-[[(2R,4AS,5R,10BS)-3,4,4A,5,6,10B-六氢-5-苯基-9-(三氟甲基)-2H-吡喃并[3,2-C]喹啉-2-基]甲基]脲 | 858668-07-2 |
| GNF-7 | GNF-7 | 839706-07-9 |
| RO-0335 | RO0335 | 867365-76-2 |
| CPI-360 | EZH2抑制剂(CPI-360) | 1802175-06-9 |
| GSK2879552 | GSK2879552 | 1401966-69-5 |
| Isavuconazonium sulfate | 艾沙康唑硫酸盐 | 946075-13-4 |
| Spisulosine | 1-DEOXYSPHINGANINE (M18:0);1-DEOXYSPHINGANINE | 196497-48-0 |
| Oritavancin diphosphate | 奥利万星二磷酸盐 | 192564-14-0 |
| ACTB-1003 | ACTB-1003 | 939805-30-8 |
| LY3039478 | CRENIGACESTAT | 1421438-81-4 |
| Idronoxil (Phenoxodiol) | 脱氢雌马酚 | 81267-65-4 |
| AZD-5069 | AZD5069 | 878385-84-3 |
| ITI-214 phosphate salt | 1642303-38-5 | 1642303-38-5 |
| BLU-554 | BLU554 | 1707289-21-1 |
| Vaborbactam | 法硼巴坦 | 1360457-46-0 |
| Sarolaner | 沙罗拉纳 | 1398609-39-6 |
| Elinogrel | 5-氯-N-[[[4-[6-氟-1,4-二氢-7-(甲基氨基)-2,4-二氧代-3(2H)-喹唑啉基]苯基]氨基]羰基]-2-噻吩磺酰胺 | 936500-94-6 |
| 9-hydroxyellipticine HCl salt | Nsc264136 | 52238-35-4 |
| NKP-1339 | CS-2765 | 197723-00-5 |
| L-778123 HCl | 4-[[5-[[4-(3-氯苯基)-3-氧代-1-哌嗪基]甲基]-1H-咪唑-1-基]甲基]苯甲腈单盐酸盐 | 253863-00-2 |
| AZD8835 | AZD-8835 | 1620576-64-8 |
| BAZ2-ICR | BAZ2-ICR | 1665195-94-7 |
| Avatrombopag | 阿伐曲泊帕 | 570406-98-3 |
| Polmacoxib | 帕马考昔 | 301692-76-2 |
| Remogliflozin etabonate | 瑞格列净乙酸酯 | 442201-24-3 |
| Taprenepag | TAPRENEPAG | 752187-80-7 |
| HE-3235 | HE3235 | 183387-50-0 |
| PF-3274167 | PF-3274167 | 900510-03-4 |
| X-396 | 恩沙替尼 | 1365267-27-1 |
| MSX-122 | MSX 122 | 897657-95-3 |
| HUHS015 | HUHS015 | 1453097-13-6 |
| CB-5083 | CB5083 | 1542705-92-9 |
| Bempedoic acid | 贝派地酸 | 738606-46-7 |
| NCT-501 | CS-2069 | 1802088-50-1 |
| Trabodenoson | trabodenoson | 871108-05-3 |
| ON-123300 | 8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 | 1357470-29-1 |
| Danirixin | GSK1325756 | 954126-98-8 |
| SKQ1 | SKQ1溴化物 | 934826-68-3 |
| GNE-495 | GNE-495 | 1449277-10-4 |
| Purpurogallin | 红陪酚 | 569-77-7 |
| Exherin | N-钙粘蛋白拮抗剂 | 229971-81-7 |
| Ceralifimod | ceralifimod | 891859-12-4 |
| SW044248 | SW-044248 | 522650-83-5 |
| I-BRD9 | GSK602 | 1714146-59-4 |
| Asapiprant | CS-2811 | 932372-01-5 |
| Evocalcet | 伊万卡赛 | 870964-67-3 |
| Cinolazepam | 西诺西泮 | 75696-02-5 |
| E3330 | E 3330 | 136164-66-4 |
| AP1903 | AP1903 | 195514-63-7 |
| RRX-001 | RRX-001 | 925206-65-1 |
| SM-164 | SM 164 | 957135-43-2 |
| Emeramide (BDTH2) | N,N'-二(2-巯基乙基)间苯二甲酰胺 | 351994-94-0 |
| GDC-0810 (ARN-810) | (E)-3-(4-((E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL)PHENYL)ACRYLIC ACID | 1365888-06-7 |
| VPS34-IN1 | VPS34-IN1 | 1383716-33-3 |
| AZ7371 | N-(2-羟基乙基)-1-[(6-甲氧基-5-甲基嘧啶-4-基)甲基]-6-甲基-1H-吡咯并[3,2-B]吡啶-3-甲酰胺 | 1494675-86-3 |
| Zoliflodacin | ANGIONTENSIN(1-7) | 1620458-09-4 |
联系方式
